Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density

Bone

Volumn 35, Issue 4, 2004, Pages 957-964

  Macdonald, H M ^a,d   McGuigan, F E ^a   Fraser, W D ^b   New, S A ^c   Ralston, S H ^a   Reid, D M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d Woolmanhill Hospital   (United Kingdom)

Author keywords

BMD; MTHFR; Riboflavin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; PYRIDOXINE; RIBOFLAVIN;

ADULT; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; ELDERLY CARE; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; FRACTURE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOTE; HUMAN; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PHARMACOGENETICS; POPULATION RISK; POSTMENOPAUSE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RIBOFLAVIN;

EID: 5344224747     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.05.018     Document Type: Article

References (36)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA. 285:2001;785-795
2. Cooper G.S., Umbach D.M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J. Bone Miner. Res. 11:1996;1841-1849
3. Becherini L., Gennari L., Masi L., Mansani R., Massart F., Morelli A., et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum. Mol. Genet. 9:2000;2043-2050
4. Cauley J.A., Zmuda J.M., Yaffe K., Kuller L.H., Ferrell R.E., Wisniewski S.R., et al. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - The study of osteoporotic fractures. J. Bone Miner. Res. 14:1999;1175-1181
5. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J. Bone Miner. Res. 13:1998;1569-1576
6. Grant S.F.A, Reid D.M., Blake G., Herd R., Fogelman I., Ralston S.H. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha1 gene. Nat. Genet. 14:1996;203-205
7. Miyao M., Morita H., Hosoi T., Kurihara H., Inoue S., Hoshino S., et al. Association of methylenetetrahydrofolate reductase (MHTFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue Int. 66:2000;190-194
8. Devoto M., Shimoya K., Caminis J., Ott J., Tenenhouse A., Whyte M.P., et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur. J. Hum. Genet. 6:1998;151-157
9. Devoto M., Specchia C., Li H.H., Caminis J., Tenenhouse A., Rodriguez H., et al. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum. Mol. Genet. 10:2001;2447-2452
10. Wilson S.G., Reed P.W., Bansal A., Chiano M., Lindersson M., Langdown M., et al. Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am. J. Hum. Genet. 72:2003;144-155
11. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113
12. Abrahamsen B., Madsen J.S., Tofteng C.L., Stilgren L., Bladbjerg E.M., Kristensen S.R., et al. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J. Bone Miner. Res. 18:2003;723-729
13. Jorgensen H.L., Madsen J.S., Madsen B., Saleh M.M., Abrahamsen B., Fenger M., et al. Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A Case Control Study in Danish Postmenopausal Women. Calcif. Tissue Int. 71:2002;386-392
14. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 350:2004;2033-2041
15. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., Broe K.E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350:2004;2042-2049
16. McNulty H., McKinley M.C., Wilson B., McPartlin J., Strain J.J., Weir D.G., et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am. J. Clin. Nutr. 76:2002;436-441
17. Macdonald H.M., New S.A., Campbell M.K., Reid D.M. Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy. Int. J. Obes. Relat. Metab. Disord. 27:2003;669-676
18. Macdonald H.M., New S.A., Golden M.H.N., Campbell M.K., Reid D.M. Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect for calcium, alcohol, and fruit and vegetable nutrients; and a detrimental effect for fatty acids. Am. J. Clin. Nutr. 79:2004;155-165
19. New SA. An epidemiological investigation into the influence of nutritional factors on bone mineral density and bone metabolism. Scotland, UK: PhD Thesis, University of Aberdeen; 1995.
20. Bodner C.H., Soutar A., New S.A., Scaife A.R., Byres M., Henderson G.D., et al. Validation of a food frequency questionnaire for use in a Scottish population: correlation of antioxidant vitamin intakes with biochemical measures. J. Hum. Nutr. Diet. 11:1998;373-380
21. Black D., Duncan A., Robins S.P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal. Biochem. 169:1988;197-203
22. MacDonald A.G., Birkinshaw G., Durham B., Bucknall R.C., Fraser W.D. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br. J. Rheumatol. 36:1997;50-53
23. Holland B., Welch A.A., Unwin I.D., Buss D.H., Paul A.A., Southgate D.A.T. McCance and Widdowson's the composition of foods. 1992;Royal Society of Chemistry, Cambridge, UK
24. Willett W.C., Howe G.R., Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am. J. Clin. Nutr. 65:1997;1220S-1228S
25. Selhub J.M.J.W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by s-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55:1992;131-138
26. Liu G., Nellaiappan K., Kagan H.M. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. J. Biol. Chem. 51:1997;32370-32377
27. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., Boers G.H.J. Evidence for McKuisik's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta. 1315:1996;159-162
28. Guenther B.D., Sheppard C.A., Tran P., Rozen R., Matthews R.G., Ludwig M.L. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat. Struct. Biol. 6:1999;359-365
29. Henderson L., Irving K., Gregory J., et al. National diet and nutrition survey: adults aged 19 to 64 years. Vitamin and Mineral Intake and Urinary Analytes. vol. 3:2003;TSO, London
30. Henderson L., Gregory J., Swan G. National diet and nutrition survey: adults aged 19 to 64 years. Types and Quantities of Foods Consumed. vol. 1:2003;TSO, London
31. Danish Dairy Board Diary Statistics 2002. 2003;Danish Dairy Board, Arhus, Denmark
32. Hustad S., Ueland P.M., Vollset S.E., Zhang Y., Bjorke-Monsen A.L., Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin. Chem. 46:2000;1065-1071
33. Jacques P.F., Kalmbach R., Bagley P.J., Russo G.T., Rogers G., Wilson P.W., et al. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J. Nutr. 132:2002;283-288
34. Ganji V., Kafai M.R. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National health and nutrition examination survey, 1988-1994. Am. J. Clin. Nutr. 77:2003;826-833
35. Hak A.E., Polderman K.H., Westendorp I.C., Jakobs C., Hofman A., Witteman J.C., et al. Increased plasma homocysteine after menopause. Atherosclerosis. 149:2000;163-168
36. Madigan S.M., Tracey F., McNulty H., Eaton-Evans J., Coulter J., McCartney H., et al. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. Am. J. Clin. Nutr. 68:1998;389-395